Skip to main content
Equibles

EntryPoint Capital, LLC

Position in PALI — Palisade Bio, Inc.

CIK 1992519 NEW YORK, NY
Back to PALI Full portfolio

Position in PALI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$164,060
+$24,944 QoQ
Shares Held
78,498
-1.3% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#69
of 124 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PALI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

EntryPoint Capital, LLC holds $21,800,288 across 60 Biotechnology names. PALI ranks #50 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UPB
Upstream Bio, Inc.
 129,446 $895,766
2 RARE
Ultragenyx Pharmaceutical Inc.
 25,766 $860,326
3 AUPH
Aurinia Pharmaceuticals Inc.
 48,218 $818,259
4 XENE
Xenon Pharmaceuticals Inc.
 13,177 $795,363
5 FULC
Fulcrum Therapeutics, Inc.
 217,199 $794,948
6 INCY
Incyte Corp
 6,483 $734,912
7 IMCR
Immunocore Holdings plc
 22,815 $724,376
8 RVMD
Revolution Medicines, Inc.
 3,574 $669,338

All Filings in PALI

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $164,060 78,498
2026-03-31 $139,116 79,495